AFT inks $U18.8m opioid licensing deal today
AUCKLAND: New Zealand-based, ASX-listed pharmaceuticals firm AFT has inked a $US18.8 million licensing deal to
AUCKLAND: New Zealand-based, ASX-listed pharmaceuticals firm AFT has inked a $US18.8 million licensing deal to